Abstract：Objective To investigate the relationship between human papilloma virus (HPV) infection and expressions of Toll-like receptor 4 (TLR4) and nuclear factor-kappa B (NF-κB) protein in breast cancer and its clinical significance. Methods A total of 50 cases of invasive cancer breast samples from January 2018 to December 2019 in Department of Breast Surgery, Liuzhou People’s Hospital, Guangxi Zhuang Autonomous Region were classified as cancer group, 30 cases of ductal atypical ductal hyperplasia (ADH) breast samples were classified as ADH group, and 30 cases of normal breast tissue were classified as normal group. Immunohistochemical staining was used to detect the positive expression of HPV16/18E6, TLR4, and NF-κB protein in three groups; the correlation between HPV16/18E6, TLR4, and NF-κB protein in cancer group and ADH group were analyzed; the relationship between positive expression of HPV16/18E6, TLR4, and NF-κB protein and clinicopathological features in cancer group were compared. Results The positive expression rate of HPV16/18E6, TLR4, and NF-κB protein among three groups were highly significantly different (P < 0.01). The positive expression rate of HPV16/18E6 in cancer group was higher than that in ADH group and normal group (P < 0.017); the positive expression rate of TLR4 and NF-κB protein cancer group was higher than that in ADH group and normal group, and ADH group was higher than normal group (P < 0.017). In cancer group and ADH group, HPV16/18E6 were positively correlated with TLR4 and NF-κB protein (P < 0.01), and TLR4 was positively correlated with NF-κB protein (P < 0.01). The positive expression rate of HPV16/18E6, TLR4, and NF-κB protein were correlated with histological grade, tumor diameter, lymph node metastasis, and clinicopathological stage (P < 0.05). Conclusion High-risk HPV infection plays an important role in the development and progression of breast cancer in conjunction with TLR4 and NF-κB inflammatory factors.
石喆1* 任珊2* 杨立1 戴文斌1. 乳腺癌组织中HPV感染与TLR4、NF-κB蛋白表达的关系及其临床意义[J]. 中国医药导报, 2022, 19(8): 11-15.
SHI Zhe1* REN Shan2* YANG Li1 DAI Wenbin1. Relationship between HPV infection and expressions of TLR4， NF-κB protein in breast cancer and its clinical significance#br#. 中国医药导报, 2022, 19(8): 11-15.
[1] 张敏璐，彭鹏，吴春晓，等.2008-2012年中国肿瘤登记地区女性乳腺癌发病和死亡分析[J].中华肿瘤杂志，2019， 41（4）：315-320.
[2] 赖建国，廖宁.2020年乳腺癌精准治疗里程碑式前进——2020年乳腺癌临床研究进展[J].循证医学，2021，21（1）：50-53.
[3] Bae JM. Two hypotheses of dense breasts and viral infection for explaining incidence of breast cancer by age group in Korean women [J]. Epidemiology Health，2014， 36：e2014020.
[4] Petry KU. HPV and cervical cancer [J]. Scand J Clin Lab Invest Suppl，2014，244：59-62.
[5] Barros MR Jr，de Oliveira THA，de Melo CML，et al. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers [J]. J Immunol Res，2018：2912671.
[6] Khodabandehlou N，Mostafaei S，Etemadi A，et al. Human papilloma virus and breast cancer：the role of inflammation and viral expressed proteins [J]. BMC Cancer，2019， 19（1）：61.
[7] Moghoofei M，Mostafaei S，Nesaei A，et al. Epstein-Barr virus and thyroid cancer：The role of viral expressed proteins [J]. J Cell Physiol，2019，234（4）：3790-3799.
[8] Salman NA，Davies G，Majidy F，et al. Association of High Risk Human Papillomavirus and Breast cancer：A UK based Study [J]. Sci Rep，2017，7：43591.
[9] 任占平，黄健辉，石喆，等.人乳头瘤病毒16、18型在乳腺癌组织中的表达[J].癌症，2000，19（1）：48-50.
[10] 石喆，任珊，戴文斌，等.乳腺浸润性导管癌组织中HPV16/18型感染和Rb蛋白的表达状态及相关性研究[J].中国医药导报，2020，17（29）：25-28.
[11] Lawson JS，Glenn WK，Salyakina D，et al. Human Papilloma Viruses and Breast Cancer [J]. Front Oncol，2015， 5：277.
[12] Haghshenas MR，Mousavi T，Moosazadeh M，et al. Human papillomavirus and breast cancer in Iran：a meta-analysis [J]. Iran J Basic Med Sci，2016，19（3）：237.
[13] Zhou Y，Li J，Ji Y，et al. Inconclusive role of human papillomavirus infection in breast cancer [J]. Infect Agent Cancer，2015，10：36.
[14] Tatarian T，Sokas C，Rufail M，et al. Intraductal Papilloma with Benign Pathology on Breast Core Biopsy：To Excise or Not? [J]. Ann Surg Oncol，2016，23（8）：2501-2507.
[15] B?覬nl?覬kke S，Blaak?覸r J，Steiniche T，et al. Evidence of No Association Between Human Papillomavirus and Breast Cancer [J]. Front Oncol，2018，8：209.
[16] Fitzgerald KA，Kagan JC. Toll-like Receptors and the Control of Immunity [J]. Cell，2020，180（6）：1044-1066.
[17] 杨庆利，冷静.TLR2和TLR4信号在肿瘤发生和发展中的作用及机制的研究进展[J].中国免疫学杂志，2021， 37（3）：382-386.
[18] Singh A，Devkar R，Basu A. Myeloid Differentiation Primary Response 88-Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell Proliferation [J]. Front Oncol，2020，10：1780.
[19] Yang J，Liu D，Khatri KS，et al. Prognostic value of toll-like receptor 4 and nuclear factor-kappaB p65 in oral squamous cell carcinoma patients [J]. Oral Surg Oral Med Oral Pathol Oral Radiol，2016，122（6）：753-764.e1.
[20] Shi S，Xu C，Fang X，et al. Expression profile of Toll like receptors in human breast cancer [J]. Mol Med Rep，2020，21（2）：786-794.
[21] Yang C，Sun Y，Ouyang X，et al. Pain May Promote Tumor Progression via Substance P-Dependent Modulation of Toll-like Receptor-4 [J]. Pain Med，2020，21（12）：3443-3450.
[22] Zusso M，Lunardi V，Franceschini D，et al. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-κB pathway [J]. Neuroinflammation，2019，16（1）：148.
[23] Zhang YC，Huo FC，Wei LL，et al. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo [J]. J Exp Clin Cancer Res，2017，36（1）：146.
[24] Lili J. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling [J]. Ebiomedicine，2019，4：188-200.
京公网安备 11010502046598号